Babylon Health’s Billion Dollar AI Bet: The Accuracy Collapse
The spectacular collapse of Babylon Health, once valued at $4.2 billion, serves as a stark reminder to investors and health system CIOs alike: the promise…
The spectacular collapse of Babylon Health, once valued at $4.2 billion, serves as a stark reminder to investors and health system CIOs alike: the promise…
The echoes of Theranos’ spectacular collapse still reverberate through healthcare, a stark reminder of the perils of hype over evidence. Yet, the investment community continues…
The specter of Theranos, a cautionary tale of unchecked innovation and devastating consequences, continues to loom large over the healthcare technology landscape. As artificial intelligence…
The recent dual enforcement actions totaling $10.6 million against Cerebral by the Department of Justice (DOJ) and the Federal Trade Commission (FTC) mark a watershed…
The landscape of digital health is increasingly fraught with concerns over data privacy, particularly as AI-driven platforms manage sensitive personal information. The Federal Trade Commission’s…
The recent 23andMe genetic data breach serves as a stark reminder for healthcare leaders: in the burgeoning era of health AI, the security of sensitive…
The Teladoc Health and Livongo merger, once heralded as a transformative union in digital health, ultimately led to a staggering $13.7 billion write-down. This financial…
The narrative of AI in healthcare is often painted with broad strokes of transformative potential, yet the critical examination of clinical evidence frequently lags behind…
The collapse of Babylon Health in 2023, once valued at $4.2 billion, with its UK assets eventually sold for £500,000, serves as a stark reminder…
The promise of artificial intelligence in healthcare is vast, yet its deployment without rigorous oversight presents significant, often underappreciated, risks to patient safety. As AI…